about
Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophreniaBridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practiceNovel psychoactive substances in young adults with and without psychiatric comorbidities.Alexithymia in eating disorders: therapeutic implicationsCriteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders.Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders.Assessment of functioning in patients with schizophrenia and schizoaffective disorder with the Mini-ICF-APP: a validation study in Italy.Clinicians' adherence to clinical practice guidelines for cardiac function monitoring during antipsychotic treatment: a retrospective report on 434 patients with severe mental illness.The Reciprocal Relationship between Suicidality and Stigma.Pattern of gene expression in different stages of schizophrenia: Down-regulation of NPTX2 gene revealed by a meta-analysis of microarray datasets.Assessment of eating disorders with the diabetes eating problems survey - revised (DEPS-R) in a representative sample of insulin-treated diabetic patients: a validation study in Italy.Novel psychoactive substance consumption is more represented in bipolar disorder than in psychotic disorders: A multicenter-observational study.The asthma-anxiety connection.The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia.Improving physical health of patients with severe mental disorders: a critical review of lifestyle psychosocial interventions.Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relatives.Delusional infestation in a patient with renal failure, metabolic syndrome, and chronic cerebrovascular disease treated with aripiprazole: a case report.Violence and mental disorders. A retrospective study of people in charge of a community mental health center.Perceived insecurity, mental health and urbanization: Results from a multicentric study.Validation of the Italian version of the Compensatory Eating and Behaviors in Response to Alcohol Consumption Scale (CEBRACS).Clinical correlates of age at onset distribution in bipolar disorder: a comparison between diagnostic subgroups.Mental disorders in obese patients with and without metabolic syndrome.Bipolar affective disorder and Parkinson's disease: a rare, insidious and often unrecognized association.Impulsivity and aggressiveness in bipolar disorder with co-morbid borderline personality disorder.Is it true remission? A study of remitted patients affected by schizophrenia and schizoaffective disorders.Social cognition in people with schizophrenia: a cluster-analytic approach.Physical activity and mental disorders: a case-control study on attitudes, preferences and perceived barriers in Italy.Long-term outcome of schizoaffective disorder. Are there any differences with respect to schizophrenia?Psychiatric comorbidity and quality of life in obese patients. Results from a case-control study.Consensus five factor PANSS for evaluation of clinical remission: effects on functioning and cognitive performances.Alcohol drinking patterns in young people: A survey-based study.The Italian Version of the Borderline Personality Disorder Severity Index IV: Psychometric Properties, Clinical Usefulness, and Possible Diagnostic Implications.The crisis in psychiatry: a public health perspective.Obesity, alexithymia and psychopathology: a case-control study.Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognitionThe modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia[Urban insecurity and fear of crime in people suffering from mental disorders: a study in 24 Mental Health Centers in Italy]Peripheral Biomarkers in Schizophrenia: A Meta-Analysis of Microarray Gene Expression Datasets
P50
Q26745792-81CE8D2F-B4A7-488C-A864-6AC649FD1C02Q26800235-DF52D592-56D4-4142-9B0B-7229D0760B42Q34009299-8C7105A3-2D03-40EA-A10F-FE16655489F5Q34456959-816B009E-052E-4E10-9B39-F8D465623823Q35057412-CBB07790-75E0-4C1A-A2FC-F670DABE2C2AQ35096476-360D0B64-7099-4356-8ABF-2512937D21E7Q36234891-0E43490B-7871-4750-B68E-97EE62E79026Q36328767-58C6EE84-0B0E-4F3B-BEAF-74E8AFEDD275Q37685407-EC5184ED-8F2E-4500-BDE7-107F55FF7E6AQ38653598-407553FD-E0EE-437C-817F-BCE768C2A4EFQ38671644-5AA37656-8D39-4096-853A-9A949C9DC43AQ38778976-493180CD-0CD4-484A-BED8-31EF125CF423Q39211601-80A47C2C-E14B-463B-98A6-8AF87CA10E8AQ39269381-F8031F72-30FC-4D7C-AB1C-B557E8F7350CQ39281175-DC31A940-2BAA-4B06-AE22-66BE2E49570FQ39291255-28120545-E2E0-43E3-803F-514A9DC8DB6AQ39450202-9EB40874-5B36-4BC0-B9C2-87E70DCA86AFQ39765467-797C42E0-8F30-4777-B217-903E24ACDFC2Q40354006-99D5EA49-B485-479E-96CA-29887F1E7B14Q40554556-5462F275-3A40-4B50-B3C7-DF0377C54016Q41464071-16E9B8E1-DFD3-4F42-B65A-DD80F498E1FCQ43436640-368BADD0-654A-48F5-81B2-DD7BCA1BB25BQ44291646-FBD303D5-7E75-4BCC-A04A-F6591D125B85Q45122123-8E74F4A2-BCEB-4304-A2DA-3D3EC3A1A9ABQ46599069-26E37883-3C9A-4772-B335-D1E8F8B2D437Q47656378-2309F10C-DE35-4DBD-AD99-40618A9D8BE9Q47832978-4DD2D227-4DE7-4B98-987F-3C77BDB2D4F8Q48084854-14D52FFA-EA2E-4DD9-B82B-7E9037294CC2Q49104457-10615E92-EBDC-4694-BF36-0B2D4727EDABQ49590987-72C83159-D81C-4053-BEB2-BD540F011146Q50148862-6044E644-FC70-45ED-871E-E2C8236CCB58Q50589983-3F3AED18-DBB8-4062-858E-D5933EEE656EQ50626979-FED25CAF-39BF-4846-B8AA-3F32ECF741EBQ51813602-D5B08D2D-FF39-4973-AA2F-DACE27C31E6CQ60545969-18055ACC-21C2-4D41-9CBA-C832A1C1AA6FQ64079958-DD2B572C-9096-48B9-9770-20A18924E01FQ85964595-B8886754-8380-4211-9E0B-92B4C5774C63Q90700687-CC47A4DB-AE03-49E0-BD29-49677D0D85E0
P50
description
researcher
@en
wetenschapper
@nl
name
Federica Pinna
@en
Federica Pinna
@nl
type
label
Federica Pinna
@en
Federica Pinna
@nl
prefLabel
Federica Pinna
@en
Federica Pinna
@nl
P106
P31
P496
0000-0002-3108-9509